Prazer Therapeutics Email Formats

Biotechnology Research • 26, Beobwon-ro 9-gil, Korea, Republic of • 11-20 Employees

Prazer Therapeutics Email Formats

Prazer Therapeutics uses 2 email formats. The most common is {last name} (e.g., doe@prazertx.com), used 54.5% of the time.

Format	Example	Percentage
{last name}	doe@prazertx.com	54.5%
{first name}.{last name}	john.doe@prazertx.com	45.5%

Key Contacts at Prazer Therapeutics

Jungjin Ahn

Cfo/ Co- Founder

Kyung-Soo Inn

Founder And Ceo

남중 김

Chief Scientific Officer/Co-Founder

Kil Lee Jong

Chief Technology Officer

Company overview

Headquarters	26, Beobwon-ro 9-gil, H Business Park, D-dong 1011-ho, Seoul, 05836, KR
Phone number	+82262171020
Website	prazertx.com
NAICS	541714
Keywords	Drug Development, Targeted Protein Degradation, Small Molecule Inhibitor
Founded	2019
Employees	11-20
Socials

About Prazer Therapeutics

Prazer Therapeutics is a biotechnology company pioneering innovative therapeutics for various intractable diseases using rational drug design and next-generation targeted protein degradation (TPD) platform called SPiDEM. Our SPiDEM-based drug candidates for neurodegenerative diseases, cancers and inflammatory diseases have demonstrated superior pharmacokinetics and efficacy as well as reduced drug resistance compared to currently available TPD technologies. Our pipeline also encompasses anti-viral therapeutics to treat chronic hepatitis B (CHB) caused by hepatitis B virus (HBV) as well as acute lung inflammation caused by coronaviruses, influenza viruses and respiratory syncytial virus (RSV).

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Senior

Entry

C-Suite

Employees by Department

Prazer Therapeutics has 10 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore Prazer Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-02-01	1	N/A
2025-05-01	5	$19,700,000

Funding Insights

$19,700,000

Total funding amount

$19,700,000

Most recent funding amount

Number of funding rounds

Prazer Therapeutics Tech Stack

Discover the technologies and tools that power Prazer Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

Apache HTTP Server

Web servers

jQuery CDN

CDN

jQuery

JavaScript libraries

DreamWeaver

Editors

Google Tag Manager

Tag managers

Slick

JavaScript libraries

PHP

Programming languages

Open Graph

Miscellaneous

GSAP

JavaScript frameworks

Google Analytics

Analytics

jQuery UI

JavaScript libraries

Frequently asked questions

Prazer Therapeutics is located in 26, Beobwon-ro 9-gil, KR.

You can reach Prazer Therapeutics at +82262171020.

Prazer Therapeutics was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

Prazer Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Prazer Therapeutics has raised a total of $19,700,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Prazer Therapeutics

Jungjin Ahn

Cfo/ Co- Founder

Kyung-Soo Inn

Founder And Ceo

남중 김

Chief Scientific Officer/Co-Founder

Kil Lee Jong

Chief Technology Officer

4.8

40,000 users